Platelet-Activating Factor in Human Normal Tears
- 1 January 2005
- journal article
- Published by Taylor & Francis in Current Eye Research
- Vol. 30 (10) , 891-896
- https://doi.org/10.1080/02713680591001629
Abstract
To measure the concentrations of platelet-activating factor (PAF) and lyso-PAF in tears of human eyes.Unilateral tear samples were collected from the conjunctival cul-de-sac of 12 healthy volunteers without any past histories of ocular surface diseases and 10 patients with allergic conjunctivitis (AC) by graduated disposable microcapillaries. C18:0-PAF, C18:0-lyso-PAF, C16:0-PAF, and C16:0-lyso-PAF levels were determined by liquid chromatography-tandem mass spectrometry (LC/MS/MS).The concentrations of C18:0-PAF, C18:0-lyso-PAF, C16:0-PAF, and C16:0-lyso-PAF in tears from healthy volunteers were 0.44 +/- 0.39, 51.7 +/- 63.4, 61.9 +/- 75.9, and 10.7 +/- 14.7 ng/ml, respectively. Higher, but not significantly different, concentrations of all the four kinds of PAF molecules were detected in tears from AC patients. Significant correlations were demonstrated between the concentrations of C18:0-PAF and C18:0-lyso-PAF (r = 0.906; p < 0.01 in normal healthy volunteers and r = 0.939; p < 0.01 in AC patients), and between those of C16:0-PAF and C16:0-lyso-PAF (r = 0.944; p < 0.01 in normal healthy volunteers and r = 0.806; p = 0.015 in AC patients). Moreover, C18:0-PAF concentrations correlated significantly with those of C16:0-PAF (r = 0.885; p < 0.01 in normal healthy volunteers and r = 0.927; p < 0.01 in AC patients), while C18:0-lyso-PAF concentrations correlated significantly with those of C16:0-lyso-PAF (r = 0.972; p < 0.01 in normal healthy volunteers and r = 0.891; p < 0.01 in AC patients).To our knowledge, this is the first report of the concentrations of different species of PAF (C18:0-PAF, C18:0-lyso-PAF, C16:0-PAF, and C16:0-lyso-PAF) in human tears.Keywords
This publication has 14 references indexed in Scilit:
- Platelet Activating Factor Degradation in Tear Fluid from Guinea Pigs with Allergic ConjunctivitisJournal of Ocular Pharmacology and Therapeutics, 2001
- Cytokine and Lipid Inflammatory Mediator Profile of Human Tears During Contact Lens Associated Inflammatory DiseasesExperimental Eye Research, 1998
- Eosinophil migration in response to three molecular species of platelet activating factorInflammation Research, 1996
- Development of a high-performance liquid chromatographic—mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samplesJournal of Chromatography A, 1993
- Synthesis of Platelet Activating Factor by Ocular Tissue From Inflamed EyesArchives of Ophthalmology (1950), 1991
- Characterization of specific binding sites for PAF in the iris and ciliary body of rabbitBiochemical and Biophysical Research Communications, 1989
- Presence of specific platelet-activating factor binding sites in the rat retinaEuropean Journal of Pharmacology, 1989
- Prostaglandin-Independent Inhibition of Ocular Vascular Permeability by a Platelet-Activating Factor AntagonistArchives of Ophthalmology (1950), 1988
- The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase productsBiochemical and Biophysical Research Communications, 1987
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972